Anebulo Pharmaceuticals (ANEB) Short Interest Ratio & Short Volume $1.59 +0.07 (+4.61%) (As of 11/15/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Anebulo Pharmaceuticals Short Interest DataAnebulo Pharmaceuticals (ANEB) has a short interest of 10,800 shares, representing 0.12% of the float (the number of shares available for trading by the public). This marks a -6.90% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.3, indicating that it would take 1.3 days of the average trading volume of 6,759 shares to cover all short positions.Current Short Interest10,800 sharesPrevious Short Interest11,600 sharesChange Vs. Previous Month-6.90%Dollar Volume Sold Short$20,304.00Short Interest Ratio1.3 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares25,933,000 sharesFloat Size9,280,000 sharesShort Percent of Float0.12%Today's Trading Volume2,443 sharesAverage Trading Volume6,759 sharesToday's Volume Vs. Average36% Short Selling Anebulo Pharmaceuticals? Sign up to receive the latest short interest report for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartANEB Short Interest Over TimeANEB Days to Cover Over TimeANEB Percentage of Float Shorted Over Time Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Anebulo Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202410,800 shares $20,304.00 -6.9%0.1%1.3 $1.88 10/15/202411,600 shares $22,040.00 -20.0%0.1%1.6 $1.90 9/30/202414,500 shares $27,985.00 -19.4%0.2%1.9 $1.93 9/15/202418,000 shares $37,440.00 +27.7%0.2%2.3 $2.08 8/31/202414,100 shares $27,072.00 +12.8%0.2%2.4 $1.92 8/15/202412,500 shares $24,250.00 -5.3%0.1%2.3 $1.94 Get the Latest News and Ratings for ANEB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/202413,200 shares $31,680.00 -8.3%0.1%2.1 $2.40 7/15/202414,400 shares $34,848.00 +15.2%0.2%2.1 $2.42 6/30/202412,500 shares $34,125.00 +13.6%0.1%1.7 $2.73 6/15/202411,000 shares $23,100.00 +4.8%0.1%1.5 $2.10 5/31/202410,500 shares $21,525.00 +69.4%0.1%2 $2.05 5/15/20246,200 shares $14,570.00 -65.4%0.1%1.1 $2.35 4/30/202417,900 shares $51,910.00 -11.0%0.2%3.2 $2.90 4/15/202420,100 shares $59,496.00 +6.9%0.2%3.6 $2.96 3/31/202418,800 shares $53,956.00 +308.7%0.2%3.4 $2.87 3/15/20244,600 shares $11,684.00 +39.4%0.1%0.5 $2.54 2/29/20243,300 shares $8,976.00 +10.0%0.0%0.4 $2.72 2/15/20243,000 shares $8,250.00 +11.1%0.0%0.3 $2.75 1/31/20242,700 shares $6,952.50 -18.2%0.1%0.2 $2.58 1/15/20243,300 shares $7,953.00 -10.8%0.2%0.2 $2.41 12/31/20233,700 shares $8,954.00 -14.0%0.2%0.2 $2.42 12/15/20234,300 shares $8,428.00 +30.3%0.2%0.2 $1.96 11/30/20233,300 shares $7,524.00 +32.0%0.2%0.2 $2.28 11/15/20232,500 shares $5,575.00 -56.1%0.1%0.1 $2.23 10/31/20235,700 shares $12,540.00 -52.5%0.3%0.4 $2.20 10/15/202312,000 shares $29,521.20 +55.8%0.4%0.9 $2.46 9/30/20237,700 shares $23,523.50 -44.6%0.3%1.2 $3.06 9/15/202313,900 shares $44,480.00 +1,444.4%0.5%2.2 $3.20 8/31/2023900 shares $2,511.00 -35.7%0.0%0.1 $2.79 8/15/20231,400 shares $4,074.00 -41.7%0.1%0.3 $2.91 7/31/20232,400 shares $5,184.00 -7.7%0.1%0.7 $2.16 7/15/20232,600 shares $6,526.00 +271.4%0.1%0.9 $2.51 6/30/2023700 shares $1,645.00 +40.0%0.0%0.2 $2.35 6/15/2023500 shares $1,125.00 +25.0%0.0%0.1 $2.25 5/31/2023400 shares $904.00 -91.7%0.0%0.1 $2.26 5/15/20234,800 shares $11,160.00 -18.6%0.1%1.4 $2.33 4/30/20235,900 shares $17,228.00 -9.2%0.1%1.6 $2.92 4/15/20236,500 shares $18,135.65 -22.6%0.1%1.4 $2.79 3/31/20238,400 shares $24,360.00 +460.0%0.2%1.6 $2.90 3/15/20231,500 shares $3,765.00 -94.0%0.0%0.3 $2.51I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 2/28/202324,900 shares $76,692.00 +6.4%0.5%4.3 $3.08 2/15/202323,400 shares $71,634.42 -19.9%0.5%3.6 $3.06 1/31/202329,200 shares $74,460.00 -24.4%0.6%3.8 $2.55 1/15/202338,600 shares $122,744.14 +0.3%0.8%5.4 $3.18 12/30/202238,500 shares $93,312.45 +1.3%0.8%5.1 $2.42 12/15/202238,000 shares $104,880.00 +49.6%0.8%4.5 $2.76 11/30/202225,400 shares $55,880.00 -5.6%0.6%3.3 $2.20 11/15/202226,900 shares $67,788.00 -9.4%0.6%4.1 $2.52 10/31/202229,700 shares $71,577.00 +29.7%1.3%3.1 $2.41 10/15/202222,900 shares $61,830.00 +9.1%1.0%2.3 $2.70 9/30/202221,000 shares $58,800.00 +78.0%0.9%2.1 $2.80 9/15/202211,800 shares $44,958.00 +35.6%0.5%0.6 $3.81 8/31/20228,700 shares $30,189.00 -71.7%0.4%0.5 $3.47 8/15/202230,700 shares $117,888.00 +192.4%1.3%1.5 $3.84 7/31/202210,500 shares $31,342.50 -33.1%0.5%0.6 $2.99 7/15/202215,700 shares $48,670.00 -13.7%0.7%1 $3.10 6/30/202218,200 shares $94,640.00 +1,720.0%0.8%1 $5.20 6/15/20221,000 shares $3,170.00 -28.6%0.0%0.1 $3.17 5/31/20221,400 shares $3,780.00 No Change0.1%0.2 $2.70 5/15/20221,400 shares $4,368.00 +250.0%0.1%0.2 $3.12 4/30/2022400 shares $1,484.00 No Change0.0%0.1 $3.71 4/15/2022400 shares $2,184.00 -50.0%0.0%0.1 $5.46 3/31/2022800 shares $5,664.00 -60.0%0.0%0.3 $7.08 3/15/20222,000 shares $13,540.00 -20.0%0.1%1 $6.77 2/28/20222,500 shares $18,225.00 No Change0.1%1.1 $7.29 2/15/20222,500 shares $16,650.25 +13.6%0.1%0.8 $6.66 1/31/20222,200 shares $14,542.00 -35.3%0.1%0.6 $6.61 1/15/20223,400 shares $23,447.08 +41.7%0.2%0.8 $6.90 12/31/20212,400 shares $14,760.00 -22.6%0.1%0.5 $6.15 12/15/20213,100 shares $19,530.00 -54.4%0.1%0.7 $6.30 11/30/20216,800 shares $40,800.00 -2.9%0.3%1.3 $6.00 11/15/20217,000 shares $45,780.00 +16.7%0.3%1.7 $6.54 10/29/20216,000 shares $39,900.00 -35.5%0.3%1.5 $6.65 10/15/20219,300 shares $66,774.00 +66.1%0.4%2.7 $7.18 9/30/20215,600 shares $36,680.00 -34.9%0.2%1.6 $6.55 9/15/20218,600 shares $59,555.00 +59.3%0.4%2.1 $6.93 8/31/20215,400 shares $36,450.00 -21.7%0.2%0.7 $6.75 8/13/20216,900 shares $48,149.58 No Change0.3%0.6 $6.98 ANEB Short Interest - Frequently Asked Questions What is Anebulo Pharmaceuticals' current short interest? Short interest is the volume of Anebulo Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 10,800 shares of ANEB short. 0.12% of Anebulo Pharmaceuticals' shares are currently sold short. Learn More on Anebulo Pharmaceuticals' current short interest. What is a good short interest ratio for Anebulo Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANEB shares currently have a short interest ratio of 1.0. Learn More on Anebulo Pharmaceuticals's short interest ratio. What is a good short interest percentage for Anebulo Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.12% of Anebulo Pharmaceuticals' floating shares are currently sold short. Is Anebulo Pharmaceuticals' short interest increasing or decreasing? Anebulo Pharmaceuticals saw a drop in short interest in October. As of October 31st, there was short interest totaling 10,800 shares, a drop of 6.9% from the previous total of 11,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Anebulo Pharmaceuticals' float size? Anebulo Pharmaceuticals currently has issued a total of 25,933,000 shares. Some of Anebulo Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Anebulo Pharmaceuticals currently has a public float of 9,280,000 shares. How does Anebulo Pharmaceuticals' short interest compare to its competitors? 0.12% of Anebulo Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Anebulo Pharmaceuticals: Tonix Pharmaceuticals Holding Corp. (5.59%), Sol-Gel Technologies Ltd. (0.39%), OptiNose, Inc. (5.68%), Scilex Holding (9.50%), Innate Pharma S.A. (0.08%), Adverum Biotechnologies, Inc. (13.39%), Skye Bioscience, Inc. (8.88%), Cardiol Therapeutics Inc. (1.23%), Compugen Ltd. (1.42%), Nuvectis Pharma, Inc. (13.65%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Anebulo Pharmaceuticals stock? Short selling ANEB is an investing strategy that aims to generate trading profit from Anebulo Pharmaceuticals as its price is falling. ANEB shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Anebulo Pharmaceuticals? A short squeeze for Anebulo Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ANEB, which in turn drives the price of the stock up even further. How often is Anebulo Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANEB, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies TNXP Short Interest Data SLGL Short Interest Data OPTN Short Interest Data SCLX Short Interest Data IPHA Short Interest Data ADVM Short Interest Data SKYE Short Interest Data CRDL Short Interest Data CGEN Short Interest Data NVCT Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANEB) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anebulo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
